Emerging Market Earnings Roundup: China Surpasses Japan As AstraZeneca’s Second Largest Market (Part 4)
This article was originally published in PharmAsia News
Executive Summary
China is now AstraZeneca’s second largest market where it out grew multinational peers including Pfizer in the first quarter.